Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study

Oncology Group ◽

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.047 ◽

2012 ◽

Vol 125 (2) ◽

pp. 315-319 ◽

Cited By ~ 22

Author(s):

Dana M. Chase ◽

Helen Q. Huang ◽

Lari Wenzel ◽

David Cella ◽

Richard McQuellon ◽

...

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-20-0276 ◽

2020 ◽

Vol 19 (11) ◽

pp. 2363-2370 ◽

Cited By ~ 1

Author(s):

Krishnansu S. Tewari ◽

Michael W. Sill ◽

Bradley J. Monk ◽

Richard T. Penson ◽

David H. Moore ◽

...

Keyword(s):

Cervical Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Gynecologic Oncology ◽

Oncology Group ◽

Final Overall Survival Analysis of the Phase III Randomized Trial of Chemotherapy with and Without Bevacizumab for Advanced Cervical Cancer: a Nrg Oncology - Gynecologic Oncology Group Study

Annals of Oncology ◽

10.1093/annonc/mdu438.27 ◽

2014 ◽

Vol 25 ◽

pp. v1 ◽

Cited By ~ 5

Author(s):

K.S. Tewari ◽

M.W. Sill ◽

R.T. Penson ◽

H. Huang ◽

L.M. Ramondetta ◽

...

Keyword(s):

Cervical Cancer ◽

Overall Survival ◽

Survival Analysis ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Overall Survival Analysis

A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.06.012 ◽

2007 ◽

Vol 107 (2) ◽

pp. 274-279 ◽

Cited By ~ 33

Author(s):

P ROSE ◽

K DEGEEST ◽

S MCMEEKIN ◽

N FUSCO

Keyword(s):

Cervical Cancer ◽

Phase I Study ◽

Gynecologic Oncology ◽

Locally Advanced ◽

Oncology Group ◽

Oncology Group Study ◽

Pelvic Radiation ◽

Locally Advanced Cervical Cancer

A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.12.431 ◽

2012 ◽

Vol 125 (1) ◽

pp. 158-162 ◽

Cited By ~ 12

Author(s):

Peter G. Rose ◽

Michael W. Sill ◽

D. Scott McMeekin ◽

Amina Ahmed ◽

Ritu Salani ◽

...

Keyword(s):

Cervical Cancer ◽

Phase I Study ◽

Gynecologic Oncology ◽

Locally Advanced ◽

Oncology Group ◽

Oncology Group Study ◽

Pelvic Radiation ◽

Locally Advanced Cervical Cancer

Complete responses in the irradiated field following treatment with chemotherapy with and without bevacizumab in advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.064 ◽

2015 ◽

Vol 137 ◽

pp. 28 ◽

Cited By ~ 2

Author(s):

R.N. Eskander ◽

J. Java ◽

B.J. Monk ◽

K.S. Tewari

Keyword(s):

Cervical Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.03.046 ◽

2015 ◽

Vol 137 (3) ◽

pp. 462-467 ◽

Cited By ~ 20

Author(s):

Chun-Chieh Wang ◽

Hung-Hsueh Chou ◽

Lan-Yan Yang ◽

Hao Lin ◽

Wen-Shiung Liou ◽

...

Keyword(s):

Cervical Cancer ◽

Randomized Trial ◽

Concurrent Chemoradiotherapy ◽

Gynecologic Oncology ◽

Single Agent ◽

Oncology Group ◽

Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.026 ◽

2015 ◽

Vol 137 ◽

pp. 12 ◽

Cited By ~ 4

Author(s):

K.S. Tewari ◽

M. Sill ◽

B.J. Monk ◽

R.T. Penson ◽

H. Lankes ◽

...

Keyword(s):

Cervical Cancer ◽

Overall Survival ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Gynecologic Oncology ◽

Oncology Group ◽

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.10.039 ◽

2006 ◽

Vol 101 (2) ◽

pp. 296-304 ◽

Cited By ~ 38

Author(s):

Richard P. McQuellon ◽

Howard T. Thaler ◽

David Cella ◽

David H. Moore

Keyword(s):

Quality Of Life ◽

Cervical Cancer ◽

Randomized Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

A phase I trial of tailored radiation therapy with concomitant cetuximab and cisplatin in the treatment of patients with cervical cancer: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.08.030 ◽

2012 ◽

Vol 127 (3) ◽

pp. 456-461 ◽

Cited By ~ 23

Author(s):

Kathleen N. Moore ◽

Michael W. Sill ◽

David S. Miller ◽

Carolyn McCourt ◽

Koen De Geest ◽

...

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽